CD19 and graft versus host disease: A retrospective study analyzed 25 patients undergoing hematopoietic stem cell allograft with CD19-directed CAR-T cell therapy, 11 of whom developed symptoms of suspected GvHD, and three patients (12%) were diagnosed with GvHD induced by CAR-T cell therapy [112].